The association of statins use with survival of patients with COVID-19.

Kuno, Toshiki; So, Matsuo; Iwagami, Masao; Takahashi, Mai; Egorova, Natalia N

Kuno, Toshiki; So, Matsuo; Iwagami, Masao; Takahashi, Mai; Egorova, Natalia N.

Afiliación

Kuno T; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA; Department of Cardiology, Montefiore Medical Center, Albert Einstein Medical College, New York, NY, USA. Electronic address: tkuno@montefiore.org.
So M; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
Iwagami M; Department of Health Services Research, University of Tsukuba, Ibaraki, Japan.
Takahashi M; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
Egorova NN; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.

J Cardiol ; 79(4): 494-500, 2022 04.

Article en En | MEDLINE | ID: mdl-34974938

Asunto(s)

COVID-19; Dislipidemias; Inhibidores de Hidroximetilglutaril-CoA Reductasas; Mortalidad Hospitalaria; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; Estudios Retrospectivos; SARS-CoV-2

Palabras clave

COVID-19; Statin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Dislipidemias / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google